Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Liquid biopsies can detect biomarkers carrying information on the development and progression of cancer. We demonstrated that a 24 plasma-based microRNA signature classifier (MSC) was capable of increasing the specificity of low dose computed tomography (LDCT) in a lung cancer screening trial. In th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Sestini, Stefano, Boeri, Mattia, Marchiano, Alfonso, Pelosi, Giuseppe, Galeone, Carlotta, Verri, Carla, Suatoni, Paola, Sverzellati, Nicola, La Vecchia, Carlo, Sozzi, Gabriella, Pastorino, Ugo
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741735/
https://ncbi.nlm.nih.gov/pubmed/26451608
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars